Alisa S Wolberg Selected Research

Neoplasms (Cancer)

11/2023	Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression.
11/2019	Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β-induced Serpine1.
4/2019	Fibrinogen and fibrin: An illustrated review.
1/2018	Factor XIIIA-expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking.
1/2017	New findings on venous thrombogenesis.
5/2016	Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma.
6/2012	Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alisa S Wolberg Research Topics

Disease

47	Thrombosis (Thrombus) 11/2023 - 04/2003
30	Hemorrhage 02/2024 - 06/2004
15	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 04/2003
11	Hemophilia A (Haemophilia) 02/2024 - 03/2007
10	Inflammation (Inflammations) 11/2023 - 11/2009
9	COVID-19 08/2023 - 01/2020
7	Neoplasms (Cancer) 11/2023 - 06/2012
6	Venous Thromboembolism 01/2023 - 03/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 05/2011
4	Thrombophilia 10/2013 - 01/2004
3	Wounds and Injuries (Trauma) 01/2024 - 06/2004
3	Obesity 12/2022 - 01/2020
3	Vascular System Injuries 09/2012 - 05/2008
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 06/2007 - 01/2004
2	Postpartum Hemorrhage 05/2024 - 01/2021
2	Adenocarcinoma 11/2023 - 05/2016
2	Stroke (Strokes) 01/2023 - 12/2020
2	Sepsis (Septicemia) 05/2021 - 01/2021
2	Infections 04/2019 - 09/2012
1	Carotid Artery Thrombosis 01/2024
1	Disease Progression 11/2023
1	Hereditary Angioedemas 11/2023
1	Gout 06/2023
1	Genetic Risk Score 06/2023
1	Factor XI Deficiency (Hemophilia C) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Necrosis 01/2023
1	Pulmonary Embolism 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Liver Failure 01/2023
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2023
1	Afibrinogenemia (Fibrinogen Deficiency) 12/2022
1	Peritonitis 01/2022
1	Angioedema 03/2021
1	Ischemic Stroke 12/2020

Drug/Important Bio-Agent (IBA)

34	FibrinIBA 11/2023 - 04/2003
24	Fibrinogen (Factor I)FDA Link 11/2023 - 05/2011
18	Thrombin FDA Link 11/2023 - 05/2007
12	Hemostatics (Antihemorrhagics)IBA 02/2024 - 01/2012
10	Fibrinolysin FDA Link 02/2024 - 09/2012
10	Factor XIII (Coagulation Factor XIII)IBA 01/2022 - 08/2014
9	Thromboplastin (Tissue Factor)IBA 05/2021 - 01/2004
8	estropipate (Ogen)FDA LinkGeneric 11/2023 - 09/2012
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2008
7	recombinant FVIIa (rFVIIa)FDA Link 01/2024 - 12/2005
6	Biomarkers (Surrogate Marker)IBA 05/2024 - 03/2009
6	Antifibrinolytic Agents (Antifibrinolytics)IBA 02/2024 - 03/2007
5	Prothrombin (Factor II)IBA 01/2024 - 04/2003
5	fibrin fragment D (D-dimer)IBA 01/2023 - 01/2020
4	PlasminogenIBA 02/2024 - 12/2008
4	Tranexamic Acid (AMCA)FDA Link 02/2024 - 01/2021
4	ferric chlorideIBA 01/2024 - 05/2011
4	AnticoagulantsIBA 01/2023 - 10/2014
4	Factor VIIa (Activated Factor VII)IBA 07/2018 - 12/2005
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2023 - 11/2015
3	TransglutaminasesIBA 11/2015 - 08/2014
2	Small Interfering RNA (siRNA)IBA 02/2024 - 01/2022
2	Factor VIII (Coagulation Factor VIII)IBA 01/2024 - 10/2011
2	Peptide Hydrolases (Proteases)FDA Link 11/2023 - 01/2022
2	Hormones (Hormone)IBA 08/2023 - 01/2017
2	Oral ContraceptivesIBA 01/2023 - 01/2015
2	AntithrombinsIBA 01/2023 - 03/2016
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2023 - 03/2016
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	ThrombomodulinIBA 01/2021 - 01/2021
2	AntigensIBA 12/2018 - 01/2018
2	Blood Group Antigens (Blood Groups)IBA 01/2017 - 01/2015
2	IntegrinsIBA 05/2016 - 10/2014
2	EnzymesIBA 01/2015 - 06/2004
2	AntibodiesIBA 12/2008 - 06/2007
2	Factor Xa (Coagulation Factor Xa)IBA 07/2007 - 03/2007
2	AutoantibodiesIBA 06/2007 - 10/2004
1	Lipid NanoparticlesIBA 02/2024
1	emicizumabIBA 01/2024
1	CytokinesIBA 11/2023
1	BradykininIBA 11/2023
1	Estrogens (Estrogen)FDA Link 08/2023
1	ORALIT (ORS)IBA 01/2023
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2023
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2023
1	AcidsIBA 01/2023
1	Protein CIBA 01/2023
1	Protein SIBA 01/2023
1	PolymersIBA 12/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	Fibrin Fibrinogen Degradation ProductsIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	ibrutinibIBA 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 05/2021
1	Endothelial Protein C ReceptorIBA 01/2021
1	KininsIBA 01/2021
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2021
1	Kallikreins (Kallikrein)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 12/2020

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2004
2	Ligation 12/2021 - 08/2013
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2023
1	Lasers (Laser) 01/2022